Delivery Order SPE2DB22D3016-SPE2DB26FABK8
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Zolmitriptan 5 mg orally disintegrating tablets in unit dose packaging. This competitive award, valued at $1,613.03 with a firm fixed price structure, represents a single delivery order without set-aside designation. The contract is scheduled for completion on October 22, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken,...
- This delivery order, awarded August 8, 2025, by the Defense Logistics Agency's Medical Supply Chain, procures Zolmitriptan 2.5 mg oral disintegrating tablets (unit dose, 6-count packages) from AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The firm fixed price delivery order, valued at $1,334.50, is scheduled for completion by August 11, 2025, with performance occurring at the vendor's Conshohocken facility. The award represents a...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Zolmitriptan 5 mg orally disintegrating tablets in unit dose packages of three, with a ceiling value of $4,829.14. The award was made on September 23, 2025, with an ultimate completion date of September 24, 2025, under a firm fixed-price arrangement with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a $18,142.31 delivery order to AmerisourceBergen Drug Corp for the supply of Zolmitriptan 2.5 mg tablets in unit dose packages of 6, with a completion date of August 1, 2025. This competitively awarded, firm fixed-price contract reflects no set-aside designation and represents a routine pharmaceutical procurement supporting federal healthcare operations. The contract is executed at the vendor's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,215.11 to AmerisourceBergen Drug Corp for Zolmitriptan 2.5 mg orally disintegrating tablets in unit dose packages of six on August 11, 2025. This firm fixed price delivery order, which is expected to be completed by August 12, 2025, represents a non-set-aside competitive award. The pharmaceutical product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,256.66 to AmerisourceBergen Drug Corp for the supply of Zolmitriptan 5 mg tablets (3-packs). The contract was awarded on August 7, 2025, with an ultimate completion date of August 8, 2025, and carries a firm fixed price structure with no set-aside designation. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a $38,500 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of Zolmitriptan 2.5 mg tablets. Under this order, Amerisourcebergen will deliver 6 packages of the migraine medication to a facility in Conshohocken, Pennsylvania by June 28, 2023 in support of the Defense Logistics Agency's medical supply needs. As a top 10 prime contractor on DLA's Pharmaceutical Prime Vendor contract, Amerisourcebergen routinely provides...
- The Defense Logistics Agency awarded a delivery order valued at $3,976.38 to AmerisourceBergen Drug Corp for the supply of Zolmitriptan 5 mg orally disintegrating tablets (ODT) in unit doses of three tablets per package. This contract represents a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded procurement. The award was issued on September 22, 2025, with an ultimate completion date of September 23, 2025, and the product will be delivered to...
- The Defense Logistics Agency awarded a $337 delivery order to Amerisourcebergen Drug Corporation for 2.5 mg doses of Zolmitriptan orally disintegrating tablets. As the prime contractor, Amerisourcebergen will deliver the medication to a Defense Logistics Agency facility located in Conshohocken, Pennsylvania within the period of performance between September 11-12, 2023. The firm fixed price contract was awarded utilizing Amerisourcebergen's position on an existing DLA pharmaceuticals contract...
- The Defense Logistics Agency awarded a $5,718.24 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561733303 ZOLMITRIPTAN 2.5 MG ODT UD 6S. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. Under this contract, Amerisourcebergen will provide Zolmitriptan, an oral disintegrating tablet used to treat migraine headaches, to the Defense Logistics Agency. As the prime contractor, Amerisourcebergen will leverage its...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB26FABK8Delivery Order
The Defense Logistics Agency awarded a $3,118.26 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Zolmitriptan 2.5 mg oral disintegrating tablets in unit dose packaging (6 count). The contract is classified as non-set-aside and carries an ultimate completion date of November 6, 2025, with performance to be executed at AmerisourceBergen's Conshohocken, Pennsylvania facility. This delivery order is issued under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle through December 2026 that enables the supply of pharmaceuticals and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is a critical federal vendor serving the Defense Health Agency and other government healthcare systems. The company has demonstrated sustained capability in meeting federal procurement requirements through competitive awards across a comprehensive portfolio of pharmaceutical products, ranging from specialty medications to generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This delivery order for Zolmitriptan, a migraine treatment medication, represents routine medical procurement supporting federal healthcare operations through the Defense Logistics Agency's established pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 11/5/25 |